Format

Send to

Choose Destination
Haematologica. 2019 May 9. pii: haematol.2019.220301. doi: 10.3324/haematol.2019.220301. [Epub ahead of print]

Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin's lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase 2 trial.

Author information

1
Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing,China.
2
Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu.
3
Department of Hematology, Air Force Hospital of Eastern Theater Command, Nanjing, Jiangsu, China.
4
Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing,China; xuwei10000@hotmail.com.

KEYWORDS:

Aggressive Non-Hodgkin's Lymphoma; DA-EPOCH; autologous stem cell transplantation; hemophagocytic lymphohistiocytosis; phase II study

PMID:
31073069
DOI:
10.3324/haematol.2019.220301
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center